GME Geratherm Medical AG

2.336USD2.130 EUR · XETRA+3.40%Mkt Cap: 12.64M USDP/E: —

Geratherm Medical AG, a medical technology company, develops, produces, and markets medical products for measuring vital data in Germany. It operates through Healthcare Diagnostic, Respiratory, and Incubator Systems segm…

Key Statistics

Company
Market Cap12.64M USD
Enterprise Value4.87M USD
Revenue (TTM)15.33M USD
Gross Profit11.55M USD
Net Income (TTM)-898.26K USD
Revenue/Share3.44 USD
Last Price2.336 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees136
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINDE0005495626
Valuation
P/E (Trailing)—
P/E (Forward)106.50
PEG0.74
EV/EBITDA-23.00
EV/Revenue0.32
P/S0.82
P/B0.59
EPS (TTM)-0.21 USD
EPS (Forward)0.02 USD
52W Range
2.13910% of range4.036
52W High4.036 USD
52W Low2.139 USD
Profitability
Gross Margin65.70%
Oper. Margin-9.50%
EBITDA Margin-1.38%
Profit Margin-5.11%
ROE-4.17%
ROA-3.15%
ROIC-0.43%
ROCE-0.27%
Growth
Revenue Growth-12.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.43M USD
CapEx (TTM)649.31K USD
FCF Margin5.58%
FCF Yield6.77%
Net Debt-7.26M USD
Net Debt/EBITDA34.26
Net Debt/FCF-8.49
Balance Sheet
Debt/Equity0.13
Current Ratio4.57
Quick Ratio2.90
Book Value/Sh3.93 USD
Cash/Share1.79 USD
Dividends
Fwd Div Rate0.11 USD
Trail. Div Rate0.11 USD
Div. Yield4.74%
5Y Avg Yield2.84%
Payout Ratio28.57%
Ex-Div DateJul 27, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.387 USD
Upside (mean)+87.8%
Target Range4.387 USD – 4.387 USD
# Analysts1
Ownership
Shares Out.5.41M
Float1.41M
Insiders72.47%
Institutions0.14%
Technical
SMA 502.418 (-3.4%)
SMA 2002.833 (-17.5%)
Beta0.46
S&P 52W Chg12.00%
Avg Vol (30d)1.67K
Avg Vol (10d)1.89K
Technical Indicators
RSI (14)48.9
MACD-0.0283
MACD Signal-0.0310
MACD Hist.+0.0026
BB Upper2.459 USD
BB Middle2.340 USD
BB Lower2.221 USD
BB Width10.17%
ATR (14)0.0821 USD
Vol Ratio (20d)0.11x

About Geratherm Medical (ETR: GME)

›

Geratherm Medical (ETR: GME) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 136 employees.

The shares were at 2.130 EUR on 19 November 2026, down 36.6% over 52 weeks. Its 52-week range is 1.950 EUR to 3.680 EUR: the price is 42.1% below the high and 9.2% above the low.

Its market capitalisation is 11.53M EUR. It pays a dividend yielding 4.74% (it pays out 29% of its earnings), against a median of 2.36% among the dividend payers in that peer group.

Geratherm Medical reports return on equity of -4.2%, an operating margin of -9.5% and revenue down 12.5% year over year.

It holds more cash than debt, a net cash position of 6.62M EUR. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 4.000 EUR is 87.8% above the current price.